Dyne Therapeutics, Inc. (DYN) Operating cash flow 2019–2025
Dyne Therapeutics, Inc. (DYN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$403.2MFY2025 · since FY2019: -$11.8M → -$403.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$403.2M | -37.9% |
| FY2024 | -$292.4M | -55.4% |
| FY2023 | -$188.2M | -22.5% |
| FY2022 | -$153.6M | -28.5% |
| FY2021 | -$119.6M | -157.1% |
| FY2020 | -$46.5M | -293.0% |
| FY2019 | -$11.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice